January 23, 2017

Analysis: MBL Infrastructure Limited

www.drvijaymalik.com has a dedicated section for investment & stock specific queries of readers: “Ask Your Queries”. Over time, readers have asked queries about multiple stocks in this section. Answers to these queries have been done post preliminary analysis of the stocks under consideration. Such analysis has been found helpful by readers.

Q&A Series is an attempt to summarize & share with all the readers, the key questions and their answers, which have featured on “Ask Your Queries” section. The primary aim of this new feature is to share the knowledge with all the readers of the website.

The current section of this series, “Q&A” covers MBL Infrastructure Limited, an Indian infrastructure player focusing on the construction of roads in both build operate & transfer (BOT) as well as engineering, procurement and construction (EPC) segments.

Equity research report Analysis of MBL Infrastructure Limited, an Indian infrastructure player in roads on build operate & transfer BOT and EPC segments

January 14, 2017

Register for "Peaceful Investing Workshop", Kolkata, April 9, 2017

One of the key methods to generate significant wealth from stock markets is to buy & hold fundamentally sound stocks over long periods of times extending to years and many a times to decades. However, such long investing duration invariably contain periods of exuberance & distress where the market price rises & falls significantly. It leads to strong emotional reactions from investors that make holding stocks for long term a difficult proposition.

Therefore, the patience to hold stocks in fluctuating markets requires very high level of conviction from the investor in her investing decisions.

“Peaceful Investing” workshop aims to focus on stock selection and analysis skills, which would make us much more confident about our stock decisions. It would ensure that our faith would not shake with day to day market price fluctuations and we would be able to reap true benefits of stock markets to fulfill our dream of financial independence.

Full day, fundamental, stock, investing, workshop, focusing on value investing, by Dr Vijay Malik, at kolkata, on April 9, 2017 at Hotel De Sorvani Salt Lake City

The workshop has 40 seats. Currently, 30 seats remain vacant.

January 12, 2017

Launching Premium Services section: http://premium.drvijaymalik.com

Since last few months, we were working on upgrading the website with addition of a premium services section, which could serve as one stop solution for all the premium services offered by us and also provide individual accounts to the subscribers, which can be accessed by a log in.

The idea of subscribers’ accounts was taken up as it allows investors to get access to restricted sections like “My Portfolio” as well as provides an avenue to re-download the files (Stock Analysis Excel Template compatible with Screener and the “Peaceful Investing” e-book), which they subscribe at our website.

It gives us immense pleasure to let you know that the website upgradation work has been completed and the premium section containing all the premium services of our blog is live at the following link:

January 11, 2017

Analysis: Jenburkt Pharmaceuticals Limited

www.drvijaymalik.com has a dedicated section for investment & stock specific queries of readers: “Ask Your Queries”. Over time, readers have asked queries about multiple stocks in this section. Answers to these queries have been done post preliminary analysis of the stocks under consideration. Such analysis has been found helpful by readers.

Q&A Series is an attempt to summarize & share with all the readers, the key questions and their answers, which have featured on “Ask Your Queries” section. The primary aim of this new feature is to share the knowledge with all the readers of the website.

The current section of this series, “Q&A” covers Jenburkt Pharmaceuticals Limited, an Indian pharmaceutical player.

Jenburkt Pharmaceuticals Ltd  Equity research report analysis, prescription and over-the-counter drugs, a pharmaceutical manufacturer, anti-arthritic, antimalarials, anti-osteoporotic, antibiotics, antidiabetics, anti-inflammatory drugs, Dr Vijay Malik, fundamental value stock analysis

January 5, 2017

Q&A: Consolidated vs Standalone Financials, Buyback, Bonus Shares

www.drvijaymalik.com has a section dedicated to answering queries of readers: “Ask Your Queries”. Over time, many readers have asked their queries related to many aspects of stock analysis and sought clarifications about investing. I have responded to these queries as replies to their comments.

“Q&A” series is an attempt to share the queries & their responses, which have featured on “Ask Your Queries” section, with all the readers. The primary aim of this new feature is to share the knowledge with other readers of the website, who might have similar queries.

The current article in this series provides responses related to:
  • Consolidated and standalone financials
  • Premium during buyback of shares
  • Role of current maturity of long-term debt (CMLTD) in total borrowings
  • The impact of new/bonus shares on P/E ratio, EPS etc.
  • Getting information about small/mid cap stocks 

Answers to readers' queries on consolidated vs standalone financials, buyback, new/bonus shares, mid/small cap stocks, debt CMLTD, stock equity value fundamental investing

December 31, 2016

Analysis: Poddar Pigments Limited

www.drvijaymalik.com has a dedicated section for investment & stock specific queries of readers: “Ask Your Queries”. Over time, readers have asked queries about multiple stocks in this section. Answers to these queries have been done post preliminary analysis of the stocks under consideration. Such analysis has been found helpful by readers.

Q&A Series is an attempt to summarize & share with all the readers, the key questions and their answers, which have featured on “Ask Your Queries” section. The primary aim of this new feature is to share the knowledge with all the readers of the website.

The current section of this series, “Q&A” covers Poddar Pigments Limited, a manufacturer of color & additive masterbatches for dope dyeing of man- made fibres like Polypropylene, Nylon & Polyester Multifilament Yarn/Fibers.

Analysis Poddar Pigments Limited, color & additive masterbatches, dope dyeing, Polypropylene, Nylon, Polyester, equity research report, Dr Stock, Dr Vijay Malik

December 26, 2016

Analysis: Srikalahasthi Pipes Limited (erstwhile Lanco Industries Ltd)

www.drvijaymalik.com has a dedicated section for investment & stock specific queries of readers: “Ask Your Queries”. Over time, readers have asked queries about multiple stocks in this section. Answers to these queries have been done post preliminary analysis of the stocks under consideration. Such analysis has been found helpful by readers.

Q&A Series is an attempt to summarize & share with all the readers, the key questions and their answers, which have featured on “Ask Your Queries” section. The primary aim of this new feature is to share the knowledge with all the readers of the website.

The current section of this series, “Q&A” covers Srikalahasthi Pipes Limited (erstwhile Lanco Industries Limited), currently, a part of Electrosteel group, which is involved in the manufacturing of Ductile Iron (DI) pipes, pig iron and portland slag cement.

Analysis of Srikalahasthi Pipes Limited (Lanco Industries Limited), part of Electrosteel group, manufacturing Ductile Iron (DI) pipes, pig iron and portland slag cement. Dr Vijay Malik, Dr Stock analysis

December 25, 2016

“Peaceful Investing – A Simple Guide to Hassle-free Stock Investing” e-book

www.drvijaymalik.com has a huge collections of articles, which are focused on simplifying the stock market investing for common investors. These articles cover different aspects of stock investing like:
  1. Deciding the suitable approach to stock market investing
  2. Shortlisting companies for analysis
  3. Detailed guidelines for conducting in-depth stock analysis covering: financial analysis, valuation analysis, business & industry analysis, management analysis, operating efficiency analysis etc.
  4. Ready checklists as a ready reference while doing stock selection
  5. Deciding about the price to pay for any stock
  6. Deciding when to sell the stocks in the portfolio
  7. Methods to check accounting juggleries by companies
  8. Guidelines for creation a portfolio of stocks with ideal number of stocks
  9. Guidelines for monitoring stocks in the portfolio
and many more.

All these articles are separate write-ups, which are available to all the readers at www.drvijaymalik.com.

A lot of readers have asked whether there exists an e-book compiling all these articles, which could be downloaded by the readers so that the articles could be read in a sequence even when the reader is offline.

The key stock investing articles were collected as a book and offered as a key study material guide to each of the participants of all the “Peaceful Investing” workshops being conducted by us. 

Peaceful Investing book, Value investing book, Dr Vijay Malik book, Dr Stock book, ebook, e-book, Stock Investing Guide book

December 23, 2016

Q&A: Buyback, EBITDA vs Sales Growth, NPM, CAGR vs YoY

www.drvijaymalik.com has a section dedicated to answering queries of readers: “Ask Your Queries”. Over time, many readers have asked their queries related to many aspects of stock analysis and sought clarifications about investing. I have responded to these queries as replies to their comments.

“Q&A” series is an attempt to share the queries & their responses, which have featured on “Ask Your Queries” section, with all the readers. The primary aim of this new feature is to share the knowledge with other readers of the website, who might have similar queries.

The current article in this series provides responses related to:
  • Using EBITDA growth instead of sales growth while analysing stocks
  • Usage of 10 years of financial data in stock analysis
  • Buyback of shares
  • Analysis of net profit margin of companies
  • CAGR or year on year growth rates
  • CFO vs FCF in stocks analysis

Answers to readers’ queries focused on EBIDTA vs Sales Growth, Buyback of shares, Optimal net profit margin (NPM), CAGR vs YoY growth, Dr Vijay Malik analysis